Log in to save to my catalogue

Rationale and design of the dal-OUTCOMES trial: Efficacy and safety of dalcetrapib in patients with...

Rationale and design of the dal-OUTCOMES trial: Efficacy and safety of dalcetrapib in patients with...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_DiVA_org_liu_52881

Rationale and design of the dal-OUTCOMES trial: Efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome

About this item

Full title

Rationale and design of the dal-OUTCOMES trial: Efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome

Publisher

United States: Mosby, Inc

Journal title

The American heart journal, 2009-12, Vol.158 (6), p.896-901.e3

Language

English

Formats

Publication information

Publisher

United States: Mosby, Inc

More information

Scope and Contents

Contents

Background Despite contemporary therapies for acute coronary syndrome (ACS), morbidity and mortality remain high. Low levels of high-density lipoprotein (HDL) cholesterol are common among patients with ACS and may contribute to ongoing risk. Strategies that raise levels of HDL cholesterol, such as inhibition of cholesterol ester transfer protein (C...

Alternative Titles

Full title

Rationale and design of the dal-OUTCOMES trial: Efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_swepub_primary_oai_DiVA_org_liu_52881

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_DiVA_org_liu_52881

Other Identifiers

ISSN

0002-8703,1097-6744

E-ISSN

1097-6744

DOI

10.1016/j.ahj.2009.09.017

How to access this item